Furthermore, 42 patients with pancreatic carcinoma were followed, and the survival analysis showed that the patients in the low-B7-H3 expression group was likely to have a longer overall survival compared with those in the high-B7-H3 expression group (P < 0.05). This evidence concerns the gene CD276 and exocrine pancreatic carcinoma.